| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.524 | 53.603 | 856 | 2.149 | 3.311 | 3.183 | 3.591 | 6.002 | 6.002 | 6.805 |
| Total Income - EUR | 54.537 | 53.604 | 856 | 2.149 | 3.311 | 3.183 | 3.591 | 6.002 | 6.002 | 6.805 |
| Total Expenses - EUR | 56.708 | 17.920 | 765 | 256 | 293 | 0 | 425 | 417 | 426 | 469 |
| Gross Profit/Loss - EUR | -2.171 | 35.685 | 92 | 1.893 | 3.019 | 3.183 | 3.166 | 5.586 | 5.575 | 6.335 |
| Net Profit/Loss - EUR | -2.171 | 34.182 | 83 | 1.859 | 2.919 | 3.092 | 3.045 | 5.405 | 4.683 | 5.322 |
| Employees | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sanofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.299 | 16.897 | 24.054 | 23.613 | 23.155 | 22.716 | 22.703 | 22.683 | 22.523 | 22.488 |
| Current Assets | 11.823 | 22.514 | 20.326 | 21.751 | 7.661 | 10.700 | 7.482 | 9.301 | 12.980 | 15.374 |
| Inventories | 4.841 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.954 | 622 | 669 | 670 | 626 | 3.798 | 759 | 54 | 54 | 0 |
| Cash | 28 | 21.892 | 19.657 | 21.080 | 7.035 | 6.902 | 6.722 | 9.247 | 12.926 | 15.374 |
| Shareholders Funds | 5.000 | 39.131 | 12.392 | 14.023 | 16.671 | 19.447 | 21.989 | 23.407 | 28.019 | 30.163 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 24.121 | 279 | 31.989 | 31.340 | 14.146 | 13.969 | 8.196 | 8.577 | 7.484 | 7.699 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Sanofarm S.r.l.